Literature DB >> 12788476

Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications.

Pilar Martín-Gallán1, Antonio Carrascosa, Miguel Gussinyé, Carmen Domínguez.   

Abstract

The aims of the study were to ascertain the potential role of oxidative stress in the onset of disease-related pathophysiological complications in young type 1 diabetes patients. Indicative parameters of lipoperoxidation, protein oxidation, and changes in antioxidant defense system status were measured in blood samples from 26 young diabetic patients with recently diagnosed (< 6 months) microangiopathy (+DC), 28 diabetic patients without complications (-DC), and 40 healthy age-matched controls (CR). Both diabetic groups presented similar fructosamine and glycated hemoglobin (HbA1c) values. Results showed erythrocyte glutathione peroxidase activity, glutathione content, and plasma beta-carotene to be significantly lower in diabetic patients compared with control subjects, but with no significant differences between -DC and +DC groups. Antioxidant enzyme superoxide dismutase activity was significantly higher in the erythrocytes of diabetic patients independently of the presence of microvascular complications. However, the plasma alpha-tocopherol/total lipids ratio was significantly diminished in +DC group compared with -DC (p =.008). Lipid peroxidation indices measured in plasma included malondialdehyde, lipid hydroperoxides, and lipoperoxides, which were significantly elevated in our diabetic patients regardless of the presence of complications. Evidence of oxidative damage to proteins was shown both through the quantification of plasma protein carbonyl levels, which were significantly higher in -DC (0.61 +/- 0.09 mmol/mg prot), and higher still in the +DC patients (0.75 +/- 0.09 mmol/mg prot) compared with those of controls (0.32 +/- 0.03 mmol/mg prot; p <.01) and immunoblot analysis of protein-bound carbonyls. Additionally, a marked increase in protein oxidation was observed in +DC patients through assessment of advanced oxidation protein products (AOPP) considered to be an oxidized albumin index; AOPP values were significantly higher in +DC than in -DC patients (p <.01) and CR (p <.0001). These results point to oxidatively modified proteins as a differential factor possibly related to the pathogenesis of diabetic complications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788476     DOI: 10.1016/s0891-5849(03)00185-0

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  82 in total

1.  Advanced oxidation protein products activate intrarenal renin-angiotensin system via a CD36-mediated, redox-dependent pathway.

Authors:  Wei Cao; Jie Xu; Zhan Mei Zhou; Guo Bao Wang; Fan Fan Hou; Jing Nie
Journal:  Antioxid Redox Signal       Date:  2012-07-30       Impact factor: 8.401

2.  Advanced oxidation protein products promote NADPH oxidase-dependent β-cell destruction and dysfunction through the Bcl-2/Bax apoptotic pathway.

Authors:  Min Liang; Aiqing Li; Aiju Lou; Xifang Zhang; Youyuan Chen; Lei Yang; Yumin Li; Shenglin Yang; Fan Fan Hou
Journal:  Lab Invest       Date:  2017-03-06       Impact factor: 5.662

Review 3.  In utero oxidative stress epigenetically programs antioxidant defense capacity and adulthood diseases.

Authors:  Rita S Strakovsky; Yuan-Xiang Pan
Journal:  Antioxid Redox Signal       Date:  2012-01-11       Impact factor: 8.401

4.  The effect of grape seed extracts on serum paraoxonase activities in streptozotocin-induced diabetic rats.

Authors:  Aysel Kiyici; Nilsel Okudan; Hakki Gökbel; Muaz Belviranli
Journal:  J Med Food       Date:  2010-06       Impact factor: 2.786

5.  Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease.

Authors:  Christopher L Gentile; Angela M Nivala; Jon C Gonzales; Kyle T Pfaffenbach; Dong Wang; Yuren Wei; Hua Jiang; David J Orlicky; Dennis R Petersen; Michael J Pagliassotti; Kenneth N Maclean
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-28       Impact factor: 3.619

6.  Fructose-1,6-bisphosphate and N-acetylcysteine attenuate the formation of advanced oxidation protein products, a new class of inflammatory mediators, in vitro.

Authors:  Guilherme Vargas Bochi; Vanessa Dorneles Torbitz; Lara Peruzzolo Cargnin; Manuela Borges Sangoi; Roberto Christ Vianna Santos; Patrícia Gomes; Rafael Noal Moresco
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

Review 7.  Insulin Regulation of Proteostasis and Clinical Implications.

Authors:  Haleigh A James; Brian T O'Neill; K Sreekumaran Nair
Journal:  Cell Metab       Date:  2017-07-14       Impact factor: 27.287

8.  Oxidant/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus.

Authors:  Roberto Hernández-Marco; Pilar Codoñer-Franch; Sara Pons Morales; Cristina Del Castillo Villaescusa; Laura Boix García; Victoria Valls Bellés
Journal:  Pediatr Nephrol       Date:  2008-09-10       Impact factor: 3.714

9.  Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial.

Authors:  David R McCance; Valerie A Holmes; Michael J A Maresh; Christopher C Patterson; James D Walker; Donald W M Pearson; Ian S Young
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321

10.  L-arginine supplementation normalizes bone turnover and preserves bone mass in streptozotocin-induced diabetic rats.

Authors:  P Pennisi; G Clementi; A Prato; T Luca; G Martinez; R A Mangiafico; I Pulvirenti; F Muratore; C E Fiore
Journal:  J Endocrinol Invest       Date:  2009-05-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.